Demo
DYNT Nasdaq· Dynatronics Corp
FundamentalsNews digest Peer analysis
Login
DYNT Nasdaq· Dynatronics Corp
Earnings report Q4 2023

Dynatronics Corporation Reports Decrease in Revenue for the Latest Quarter

Segments of Revenue

Dynatronics Corporation reported net sales of $8.15 million for the three months ended December 31, 2023. This represents a decrease of 25% compared to the same period last year when net sales were $10.88 million. For the six months ended December 31, 2023, net sales were $17.50 million, a decrease of 24% compared to $22.94 million in the prior year.

Strengths

Despite the decrease in revenue, Dynatronics Corporation remains committed to providing high-quality restorative products designed to accelerate achieving optimal health. The company's broad range of products for clinical use in physical therapy, rehabilitation, orthopedics, pain management, and athletic training continues to be in demand among orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, and hospitals.

Challenges

The decrease in revenue for the latest quarter is a significant challenge for Dynatronics Corporation. The company experienced a decline in net sales of 25% compared to the same period last year. This decline can be attributed to various factors, including market competition, changes in customer preferences, and the ongoing impact of the COVID-19 pandemic on the healthcare industry.

Noteworthy

It is worth noting that Dynatronics Corporation incurred an operating loss of $901,712 for the three months ended December 31, 2023, compared to an operating loss of $799,520 in the same period last year. The company also reported a net loss of $1.01 million for the latest quarter, compared to a net loss of $840,867 in the prior year. These financial results indicate the challenges faced by the company in maintaining profitability amidst the decline in revenue.

Summary

Dynatronics Corporation reported a decrease in revenue for the latest quarter, with net sales declining by 25% compared to the same period last year. The company's commitment to providing high-quality restorative products remains a strength, but it faces challenges such as market competition and the ongoing impact of the COVID-19 pandemic. The operating loss and net loss incurred further highlight the difficulties in maintaining profitability. Dynatronics Corporation will need to address these challenges and explore strategies to drive revenue growth in the future.

Source documents

Form 10-Q  filed on Feb 07, 2024
77 pages scanned

Reference data

Company financials Q4 revenue 8.2M
Analyst estimates Q4 EPS beat by 8.00%
Sign up to Fey

Get in-depth analysis on thousands of stocks for just $30/month. Cancel anytime.